{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:49:07Z","timestamp":1791503347480,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":109,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"DOI":"10.1038\/s41523-026-00994-1","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T17:46:27Z","timestamp":1782150387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of breast cancer risk factors on the tumor microenvironment: a morphological deep-learning analysis of three prospective cohorts"],"prefix":"10.1038","volume":"12","author":[{"given":"Clara","family":"Bodelon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Amgad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha A. T.","family":"Elsebaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariah","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulla M.","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia M.","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpa V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee A. D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren R.","family":"Teras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"994_CR1","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson, N. M. & Simon, M. C. The tumor microenvironment. Curr. Biol. 30, R921\u2013R925 (2020).","journal-title":"Curr. Biol."},{"key":"994_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41, 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"key":"994_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13046-024-03236-z","volume":"43","author":"TS Hulahan","year":"2024","unstructured":"Hulahan, T. S. & Angel, P. M. From ductal carcinoma in situ to invasive breast cancer: the prognostic value of the extracellular microenvironment. J. Exp. Clin. Cancer Res. 43, 329 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"994_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/bcr921","volume":"6","author":"SE Hankinson","year":"2004","unstructured":"Hankinson, S. E., Colditz, G. A. & Willett, W. C. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res. 6, 213 (2004).","journal-title":"Breast Cancer Res."},{"key":"994_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-021-01482-z","volume":"23","author":"C Bodelon","year":"2021","unstructured":"Bodelon, C. et al. Mammary collagen architecture and its association with mammographic density and lesion severity among women undergoing image-guided breast biopsy. Breast Cancer Res. 23, 105 (2021).","journal-title":"Breast Cancer Res."},{"key":"994_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3689","volume":"16","author":"M Rotunno","year":"2014","unstructured":"Rotunno, M. et al. Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status. Breast Cancer Res. 16, R74 (2014).","journal-title":"Breast Cancer Res."},{"key":"994_CR7","doi-asserted-by":"publisher","first-page":"7020","DOI":"10.1158\/1078-0432.CCR-09-1126","volume":"15","author":"MA Troester","year":"2009","unstructured":"Troester, M. A. et al. Activation of host wound responses in breast cancer microenvironment. Clin. Cancer Res. 15, 7020\u20137028 (2009).","journal-title":"Clin. Cancer Res."},{"key":"994_CR8","first-page":"OF12","volume":"1","author":"M Abubakar","year":"2024","unstructured":"Abubakar, M. et al. Contribution of prediagnostic host factors to shaping the stromal microenvironment of breast cancer among sub-Saharan African women. Cancer Epidemiol., Biomark. Prev. 1, OF12 (2024).","journal-title":"Cancer Epidemiol., Biomark. Prev."},{"key":"994_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado, R. et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann. Oncol. 26, 259\u2013271 (2015).","journal-title":"Ann. Oncol."},{"key":"994_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10555-018-9768-3","volume":"37","author":"JM Houthuijzen","year":"2018","unstructured":"Houthuijzen, J. M. & Jonkers, J. Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment. Cancer Metastasis Rev. 37, 577\u2013597 (2018).","journal-title":"Cancer Metastasis Rev."},{"key":"994_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00346-1","volume":"7","author":"K El Bairi","year":"2021","unstructured":"El Bairi, K. et al. The tale of TILs in breast cancer: a report from The International Immuno-Oncology Biomarker Working Group. npj Breast Cancer 7, 150 (2021).","journal-title":"npj Breast Cancer"},{"key":"994_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer 20, 174\u2013186 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"994_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41591-023-02643-7","volume":"30","author":"M Amgad","year":"2024","unstructured":"Amgad, M. et al. A population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer. Nat. Med 30, 85\u201397 (2024).","journal-title":"Nat. Med"},{"key":"994_CR14","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","volume":"25","author":"DSM Chan","year":"2014","unstructured":"Chan, D. S. M. et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann. Oncol. 25, 1901\u20131914 (2014).","journal-title":"Ann. Oncol."},{"key":"994_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01099-2","volume":"32","author":"Z Cao","year":"2025","unstructured":"Cao, Z. et al. Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects. J. Biomed. Sci. 32, 7 (2025).","journal-title":"J. Biomed. Sci."},{"key":"994_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-019-0128-4","volume":"5","author":"CK Blair","year":"2019","unstructured":"Blair, C. K. et al. Obesity and survival among a cohort of breast cancer patients is partially mediated by tumor characteristics. NPJ Breast Cancer 5, 33 (2019).","journal-title":"NPJ Breast Cancer"},{"key":"994_CR17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41388-024-02954-0","volume":"43","author":"CB Lagarde","year":"2024","unstructured":"Lagarde, C. B. et al. Obesity-associated epigenetic alterations and the obesity-breast cancer axis. Oncogene 43, 763\u2013775 (2024).","journal-title":"Oncogene"},{"key":"994_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor, M. F. & Hotamisligil, G. S. Inflammatory mechanisms in obesity. Annu Rev. Immunol. 29, 415\u2013445 (2011).","journal-title":"Annu Rev. Immunol."},{"key":"994_CR19","doi-asserted-by":"crossref","unstructured":"Kolb, R. & Zhang, W. Obesity and breast cancer: a case of inflamed adipose tissue. Cancers 12, 1686 (2020)","DOI":"10.3390\/cancers12061686"},{"key":"994_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10555-022-10031-9","volume":"41","author":"LE Hillers-Ziemer","year":"2022","unstructured":"Hillers-Ziemer, L. E., Kuziel, G., Williams, A. E., Moore, B. N. & Arendt, L. M. Breast cancer microenvironment and obesity: challenges for therapy. Cancer Metastasis Rev. 41, 627\u2013647 (2022).","journal-title":"Cancer Metastasis Rev."},{"key":"994_CR21","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-22-1031","volume":"29","author":"KB Kennel","year":"2023","unstructured":"Kennel, K. B., Bozlar, M., De Valk, A. F. & Greten, F. R. Cancer-associated fibroblasts in inflammation and antitumor immunity. Clin. Cancer Res 29, 1009\u20131016 (2023).","journal-title":"Clin. Cancer Res"},{"key":"994_CR22","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1038\/s41388-021-01870-x","volume":"40","author":"B Li","year":"2021","unstructured":"Li, B. et al. Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types. Oncogene 40, 4686\u20134694 (2021).","journal-title":"Oncogene"},{"key":"994_CR23","doi-asserted-by":"publisher","first-page":"101417","DOI":"10.1016\/j.smim.2020.101417","volume":"48","author":"R Mhaidly","year":"2020","unstructured":"Mhaidly, R. & Mechta-Grigoriou, F. Fibroblast heterogeneity in tumor micro-environment: role in immunosuppression and new therapies. Semin Immunol. 48, 101417 (2020).","journal-title":"Semin Immunol."},{"key":"994_CR24","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1200\/JCO.2006.10.3168","volume":"26","author":"GC Barnett","year":"2008","unstructured":"Barnett, G. C. et al. Risk factors for the incidence of breast cancer: do they affect survival from the disease? J. Clin. Oncol. 26, 3310\u20133316 (2008).","journal-title":"J. Clin. Oncol."},{"key":"994_CR25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1001\/jama.2017.11217","volume":"318","author":"JE Manson","year":"2017","unstructured":"Manson, J. E. et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women\u2019s Health Initiative Randomized Trials. JAMA 318, 927\u2013938 (2017).","journal-title":"JAMA"},{"key":"994_CR26","doi-asserted-by":"crossref","unstructured":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350, 1047\u20131059 (1997).","DOI":"10.1016\/S0140-6736(97)08233-0"},{"key":"994_CR27","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nm1197-1209","volume":"3","author":"GS Ashcroft","year":"1997","unstructured":"Ashcroft, G. S. et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat. Med 3, 1209\u20131215 (1997).","journal-title":"Nat. Med"},{"key":"994_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1196\/annals.1386.024","volume":"1089","author":"MB Buck","year":"2006","unstructured":"Buck, M. B. & Knabbe, C. TGF-beta signaling in breast cancer. Ann. N. Y Acad. Sci. 1089, 119\u2013126 (2006).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"994_CR29","doi-asserted-by":"publisher","first-page":"20009","DOI":"10.1073\/pnas.1013805107","volume":"107","author":"Y Kojima","year":"2010","unstructured":"Kojima, Y. et al. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc. Natl. Acad. Sci. USA 107, 20009\u201320014 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"994_CR30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nm.4494","volume":"24","author":"P Roswall","year":"2018","unstructured":"Roswall, P. et al. Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling. Nat. Med 24, 463\u2013473 (2018).","journal-title":"Nat. Med"},{"key":"994_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jamcollsurg.2008.12.001","volume":"208","author":"JL Gnerlich","year":"2009","unstructured":"Gnerlich, J. L. et al. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J. Am. Coll. Surg. 208, 341\u2013347 (2009).","journal-title":"J. Am. Coll. Surg."},{"key":"994_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0165-6","volume":"4","author":"SE Stanton","year":"2016","unstructured":"Stanton, S. E. & Disis, M. L. Clinical significance of tumor-infiltrating lymphocytes in breast cancer. J. Immunother. Cancer 4, 59 (2016).","journal-title":"J. Immunother. Cancer"},{"key":"994_CR33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2304288120","volume":"120","author":"JRW Conway","year":"2023","unstructured":"Conway, J. R. W. et al. Defined extracellular matrix compositions support stiffness-insensitive cell spreading and adhesion signaling. Proc. Natl. Acad. Sci. USA 120, e2304288120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"994_CR34","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1001\/jama.295.14.1658","volume":"295","author":"DA Berry","year":"2006","unstructured":"Berry, D. A. et al. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 295, 1658\u20131667 (2006).","journal-title":"JAMA"},{"key":"994_CR35","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1158\/0008-5472.CAN-16-2574","volume":"77","author":"J Holm","year":"2017","unstructured":"Holm, J. et al. Assessment of breast cancer risk factors reveals subtype heterogeneity. Cancer Res. 77, 3708\u20133717 (2017).","journal-title":"Cancer Res."},{"key":"994_CR36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/jnci\/djq526","volume":"103","author":"XR Yang","year":"2011","unstructured":"Yang, X. R. et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J. Natl. Cancer Inst. 103, 250\u2013263 (2011).","journal-title":"J. Natl. Cancer Inst."},{"key":"994_CR37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41588-020-0609-2","volume":"52","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat. Genet. 52, 572\u2013581 (2020).","journal-title":"Nat. Genet."},{"key":"994_CR38","first-page":"477","volume":"74","author":"AN Giaquinto","year":"2024","unstructured":"Giaquinto, A. N. et al. Breast cancer statistics 2024. CA Cancer J. Clin. 74, 477\u2013495 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"994_CR39","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1002\/cncr.101970","volume":"94","author":"EE Calle","year":"2002","unstructured":"Calle, E. E. et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 94, 2490\u20132501 (2002).","journal-title":"Cancer"},{"key":"994_CR40","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1002\/cncr.30561","volume":"123","author":"AV Patel","year":"2017","unstructured":"Patel, A. V. et al. The American Cancer Society\u2019s Cancer Prevention Study 3 (CPS-3): recruitment, study design, and baseline characteristics. Cancer 123, 2014\u20132024 (2017).","journal-title":"Cancer"},{"key":"994_CR41","doi-asserted-by":"publisher","first-page":"273S","DOI":"10.1016\/S0197-2456(00)00098-2","volume":"21","author":"PC Prorok","year":"2000","unstructured":"Prorok, P. C. et al. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin. Trials 21, 273S\u2013309S (2000).","journal-title":"Control Clin. Trials"},{"key":"994_CR42","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1158\/1055-9965.EPI-16-0506","volume":"25","author":"CS Zhu","year":"2016","unstructured":"Zhu, C. S. et al. The prostate, lung, colorectal and ovarian cancer (PLCO) screening trial pathology tissue resource. Cancer Epidemiol. Biomark. Prev. 25, 1635\u20131642 (2016).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"994_CR43","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nrc1754","volume":"5","author":"DJ Hunter","year":"2005","unstructured":"Hunter, D. J. et al. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat. Rev. Cancer 5, 977\u2013985 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"994_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00663-1","volume":"10","author":"S Liu","year":"2024","unstructured":"Liu, S. et al. A panoptic segmentation dataset and deep-learning approach for explainable scoring of tumor-infiltrating lymphocytes. npj Breast Cancer 10, 52 (2024).","journal-title":"npj Breast Cancer"},{"key":"994_CR45","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jclinepi.2023.07.004","volume":"161","author":"JC Digitale","year":"2023","unstructured":"Digitale, J. C., Martin, J. N., Glidden, D. V. & Glymour, M. M. Key concepts in clinical epidemiology: collider-conditioning bias. J. Clin. Epidemiol. 161, 152\u2013156 (2023).","journal-title":"J. Clin. Epidemiol."},{"key":"994_CR46","doi-asserted-by":"publisher","first-page":"p1135","DOI":"10.1136\/bmj.p1135","volume":"381","author":"MA Hern\u00e1n","year":"2023","unstructured":"Hern\u00e1n, M. A. & Monge, S. Selection bias due to conditioning on a collider. BMJ 381, p1135 (2023).","journal-title":"BMJ"},{"key":"994_CR47","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1515\/em-2012-0010","volume":"2","author":"T VanderWeele","year":"2014","unstructured":"VanderWeele, T. & Vansteelandt, S. Mediation analysis with multiple mediators. Epidemiol. Methods 2, 95\u2013115 (2014).","journal-title":"Epidemiol. Methods"}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00994-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00994-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00994-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:54:47Z","timestamp":1791500087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00994-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["994"],"URL":"https:\/\/doi.org\/10.1038\/s41523-026-00994-1","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.A.D.C. has invention disclosures registered at the Northwestern Office of Innovation and New Ventures and consults for Tempus. The other authors declare no competing financial or non-financial interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"130"}}